ATNM
Actinium Pharmaceuticals Inc
1.10$
-7.5%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +83.9% | -10.0% | -92.1% | -100.0% | – | |
| – | – | – | – | – | – | – | – | -100.0% | – | +45.0% | -27.8% | -9.3% | +728.2% | +6.4% | +17.2% | +33.4% | +13.0% | +2.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +66.1% | -92.1% | -1,101.2% | – | |
| – | – | – | – | – | – | – | -22.5% | +360.0% | +8.5% | +31.5% | +1.1% | -3.4% | -3.2% | -2.8% | +8.8% | +32.1% | +67.1% | -22.3% | -29.7% | |
| – | -37.2% | +71.8% | -23.2% | +74.8% | -62.2% | +46,764.3% | -13.0% | +159.6% | +12.7% | -19.2% | -1.2% | -26.5% | -18.0% | +14.2% | +28.0% | +48.6% | +11.1% | -9.4% | +26.0% | |
| – | -31.6% | +120.3% | -45.0% | +74.8% | -62.2% | +82,552.1% | -17.1% | +241.2% | +10.4% | +8.1% | +0.2% | -11.5% | -9.1% | +1.4% | +16.6% | +37.3% | +48.0% | -20.6% | -12.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +222.6% | +71.9% | +32.7% | +3.4% | -28.1% | +22,993.1% | -99.8% | -65.5% | +808.5% | -36.4% | +8.4% | +3,092.6% | -100.0% | – | – | +472.1% | – | – | – | |
| – | – | – | – | – | +514.6% | -81,361.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -19.6% | +111.1% | -84.3% | +21.6% | -26.0% | +24,753.0% | -99.8% | -65.5% | +808.5% | -36.4% | -6,291.3% | – | -199.2% | – | – | – | – | – | – | |
| – | – | – | – | – | +514.6% | -81,361.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +81.4% | -52,911.0% | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.